bluebird bio Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : bluebird bio Inc.

BLUE 4.970

0.0%

Jun 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	10/18/2014 12:39:49 AM
	Read Replies (1) of 163

conversation with Dr. Rennert and Dr. Hovekamp..... Don Shimoda ?@zDonShimoda Protected Tweets 11h11 hours ago .@avidresearch 3degrees of separation...Adaptimmune spun out of Immunocore which spun out of Medigene which still owns 2.97% of Immunocore FAVORITES 4 jjzDieter HovekampavidresearchJoe Prete, Pharm.D. 4:36 AM - 18 Oct 2014 · Details Hide conversation Reply Favorite More Tweet text Reply to @zDonShimoda @avidresearch Who's in these photos? Don Shimoda ?@zDonShimoda Protected Tweets 11h11 hours ago .@avidresearch there is a licensing agreement between immunocore and adaptimmune but to my knowledge its never been disclosed Expand Reply Favorite More avidresearch ?@avidresearch 11h11 hours ago @zDonShimoda Looks like its partner $GSK is a better bet if the results hold up over time. Expand Reply Retweet Favorite More Don Shimoda ?@zDonShimoda Protected Tweets 11h11 hours ago @avidresearch sure, but holding MDG1 is so much more fun ;) I see that Don's tweets are protected. Didn't know that. I'm lucky to see them, hope you don't mind my posting them here, Don.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next